Veloxis Pharmaceuticals Releases Annual Report for 2017
February 27, 2018 14:20 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 2/2018
To: NASDAQ Copenhagen...
Veloxis Secures USD 60M in Debt Financing
February 14, 2018 15:36 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 01/2018
To: NASDAQ Copenhagen A/S ...
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017
December 31, 2017 12:00 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 27/2017
To: NASDAQ Copenhagen...
Veloxis Pharmaceuticals Announces Financial Calendar for 2018
December 29, 2017 12:13 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 26/2017
To: NASDAQ Copenhagen...
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
December 22, 2017 12:17 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 25/2017
To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 22 December...
Veloxis Increases Share Capital in Connection with Exercise of Warrants
December 01, 2017 00:00 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 24/2017
To: NASDAQ Copenhagen A/S Copenhagen,...
Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2017
November 14, 2017 11:23 ET
|
Veloxis Pharmaceuticals A/S
Highlights
Record product revenue of tUSD 5,924 achieved in Q3 2017.
Revenue reached tUSD 22,092 in the first nine months of 2017 representing an increase of 301% compared to the same...
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
October 31, 2017 18:47 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 22/2017
To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31...
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 30 September 2017
September 30, 2017 06:00 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 21/2017
To: NASDAQ Copenhagen A/S Copenhagen,...
Alastair McEwan Steps Down as Chief Operating Officer of Veloxis Pharmaceuticals A/S
September 20, 2017 17:03 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 20/2017
To: NASDAQ Copenhagen A/S ...